Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- BRISTOL MYERS SQUIBB CO
- Publication Date
- 2019-06-04
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
[0001] Cross References to Related Applications
[0002] This application claims the benefit of US Provisional Application No. 62 / 380,042, filed August 26, 2016, which is hereby incorporated by reference in its entirety. field of invention
[0003] The present invention generally relates to compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and the use of compounds of the present invention in the treatment of proliferative disorders such as cancer, viral infections and / or methods for autoimmune diseases. Background of the invention
[0004] Indoleamine 2,3-dioxygenase (IDO; also known as IDO1) is an IFN-γ target gene that plays a role in immune regulation. IDO is an oxidoreductase and is one of two enzymes that catalyze the first and rate-limiting step in the conversion of tryptophan to N-formyl-kynurenine. It exists as a 41 kD monomer found in several cell populations includ...